NSG-3250 EXAM 4 2026
EXPERT VERIFED ACE THE
TEST
Spirochete: Treponema pallidum - ANSWER ✔✔syphilis
• A painless lesion, a chancre, develops on the genitals
• The chancre may be present for up to 3-12 weeks
2-3 weeks after exposure - ANSWER ✔✔Primary stage of syphilis
• A rash develops on the trunk and extremities (hands andfeet)
• Contact with lesions can cause spread of infection
,• Other s/s include: arthritis, meningitis, fever, malaise,and weight loss -
ANSWER ✔✔Secondary stage of syphilis
causes progressive inflammatory changeswhich can impact multiple
organ
• Manifestations include: aortitis and neurosyphilis(dementia, psychosis,
paresis, stroke, or meningitis) - ANSWER ✔✔Tertiary stage of
syphilis
Syphilis management - ANSWER ✔✔• Antibiotics are the primary
method of treatment
• Penicillin G is the first line choice
• If allergic, doxycycline is alternate
• Most common in women 15-24 yrs old
• Often asymptomatic• s/s include
• Women: purulent discharge in the endocervical canal, UTI s/s, and
vaginitis• --Men: s/s are more common, burning on urination, penile
discharge, painful/swollen testis - ANSWER ✔✔Chlamydia and
gonorrhea
• Flagellated protozoan
, • Per the CDC, about 3.7 million cases per year inthe US
• Can be asymptomatic which increases chancesof spread
• Increases risk for HIV, pregnancycomplications, infertility, and PID
• May lead to cervical cellular changes
• S/S include: malodorous vaginal discharge(may be frothy and
discolored), and vulvitismay occur leading to burning and itching -
ANSWER ✔✔Trichomoniasis
Metronidazole or Tinidazole are - ANSWER ✔✔treatments for
trichomoniasis
HSV-1 (genital herpes) - ANSWER ✔✔
PSA levels should be less than - ANSWER ✔✔<4 ng/mL
Dysuria and nocturia and high levels of PSA are indications of -
ANSWER ✔✔Prostatitis, BPH, or Prostate cancer
Tamulosin - ANSWER ✔✔helps improve urine flow
a recurrent, lifelong viral infection that has the potential for transmission
throughout the lifespan
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
3
EXPERT VERIFED ACE THE
TEST
Spirochete: Treponema pallidum - ANSWER ✔✔syphilis
• A painless lesion, a chancre, develops on the genitals
• The chancre may be present for up to 3-12 weeks
2-3 weeks after exposure - ANSWER ✔✔Primary stage of syphilis
• A rash develops on the trunk and extremities (hands andfeet)
• Contact with lesions can cause spread of infection
,• Other s/s include: arthritis, meningitis, fever, malaise,and weight loss -
ANSWER ✔✔Secondary stage of syphilis
causes progressive inflammatory changeswhich can impact multiple
organ
• Manifestations include: aortitis and neurosyphilis(dementia, psychosis,
paresis, stroke, or meningitis) - ANSWER ✔✔Tertiary stage of
syphilis
Syphilis management - ANSWER ✔✔• Antibiotics are the primary
method of treatment
• Penicillin G is the first line choice
• If allergic, doxycycline is alternate
• Most common in women 15-24 yrs old
• Often asymptomatic• s/s include
• Women: purulent discharge in the endocervical canal, UTI s/s, and
vaginitis• --Men: s/s are more common, burning on urination, penile
discharge, painful/swollen testis - ANSWER ✔✔Chlamydia and
gonorrhea
• Flagellated protozoan
, • Per the CDC, about 3.7 million cases per year inthe US
• Can be asymptomatic which increases chancesof spread
• Increases risk for HIV, pregnancycomplications, infertility, and PID
• May lead to cervical cellular changes
• S/S include: malodorous vaginal discharge(may be frothy and
discolored), and vulvitismay occur leading to burning and itching -
ANSWER ✔✔Trichomoniasis
Metronidazole or Tinidazole are - ANSWER ✔✔treatments for
trichomoniasis
HSV-1 (genital herpes) - ANSWER ✔✔
PSA levels should be less than - ANSWER ✔✔<4 ng/mL
Dysuria and nocturia and high levels of PSA are indications of -
ANSWER ✔✔Prostatitis, BPH, or Prostate cancer
Tamulosin - ANSWER ✔✔helps improve urine flow
a recurrent, lifelong viral infection that has the potential for transmission
throughout the lifespan
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
3
